Adjunctive therapies and immunomodulating agents for severe influenza

Corticosteroid therapy in intensive care unit patients with PCR-confirmed influenza A(H1N1) infection in Finland

(2015) R. LINKO et al.   ACTA ANAESTHESIOLOGICA SCANDINAVICA

High-Dose N-Acetylcysteine Therapy for Novel H1N1 Influenza Pneumonia

(2013) Kang Yiu Lai   ANNALS OF INTERNAL MEDICINE

Hyperimmune IV Immunoglobulin Treatment

(2013) Ivan F.N. Hung et al.   CHEST

Macrolide-based regimens in absence of bacterial co-infection in critically ill H1N1 patients with primary viral pneumonia

(2013) I. Martín-Loeches et al.   INTENSIVE CARE MEDICINE

Effect of statin treatments on highly pathogenic avian influenza H5N1, seasonal and H1N1pdm09 virus infections in BALB/c mice

(2012) Yohichi Kumaki et al.   Future Virology

Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza

(2012) Emili Diaz et al.   JOURNAL OF INFECTION

Azithromycin and the Risk of Cardiovascular Death

(2012) Wayne A. Ray et al.   NEW ENGLAND JOURNAL OF MEDICINE

Systemic Corticosteroids and Early Administration of Antiviral Agents for Pneumonia with Acute Wheezing due to Influenza A(H1N1)pdm09 in Japan

(2012) Koichiro Kudo et al.   PLoS One

The Effect of Rosuvastatin in a Murine Model of Influenza A Infection

(2012) Kathryn A. Radigan et al.   PLoS One

Corticosteroids in the Treatment of Community-Acquired Pneumonia in Adults: A Meta-Analysis

(2012) Wei Nie et al.   PLoS One

Corticosteroid Treatment in Critically Ill Patients with Pandemic Influenza A/H1N1 2009 Infection

(2011) Sung-Han Kim et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome

(2011) Christian Brun-Buisson et al.   AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

Antiviral effect of a selective COX-2 inhibitor on H5N1 infection in vitro

(2011) Suki M.Y. Lee et al.   ANTIVIRAL RESEARCH

Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia

(2011) Nelson Lee et al.   ANTIVIRAL THERAPY

N-acetyl-l-cysteine (NAC) inhibit mucin synthesis and pro-inflammatory mediators in alveolar type II epithelial cells infected with influenza virus A and B and with respiratory syncytial virus (RSV)

(2011) Manuel Mata et al.   BIOCHEMICAL PHARMACOLOGY

Early Use of Glucocorticoids Was a Risk Factor for Critical Disease and Death From pH1N1 Infection

(2011) K. Han et al.   CLINICAL INFECTIOUS DISEASES

Convalescent Plasma Treatment Reduced Mortality in Patients With Severe Pandemic Influenza A (H1N1) 2009 Virus Infection

(2011) I. F. Hung et al.   CLINICAL INFECTIOUS DISEASES

Effect of pravastatin on the frequency of ventilator-associated pneumonia and on intensive care unit mortality: Open-label, randomized study*

(2011) Demosthenes Makris et al.   CRITICAL CARE MEDICINE

Effect of immunomodulatory therapies in patients with pandemic influenza A (H1N1) 2009 complicated by pneumonia

(2011) Diego Viasus et al.   JOURNAL OF INFECTION

Clarithromycin has limited effects in non-elderly, non-severe patients with seasonal influenza virus A infection

(2011) Hiroshi Ishii et al.   JOURNAL OF INFECTION

Association Between Use of Statins and Mortality Among Patients Hospitalized With Laboratory-Confirmed Influenza Virus Infections: A Multistate Study

(2011) M. L. Vandermeer et al.   JOURNAL OF INFECTIOUS DISEASES

A case of acute respiratory distress syndrome associated with novel H1N1 treated with intravenous immunoglobulin G

(2011) Jen Lim Chong et al.   JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION

Dexamethasone in community-acquired pneumonia

(2011) Nelson Lee et al.   LANCET

Pre-Admission Statin Use and In-Hospital Severity of 2009 Pandemic Influenza A(H1N1) Disease

(2011) Stephen J. Brett et al.   PLoS One

Delayed Clearance of Viral Load and Marked Cytokine Activation in Severe Cases of Pandemic H1N1 2009 Influenza Virus Infection

(2010) Kelvin K. W. To et al.   CLINICAL INFECTIOUS DISEASES

Original Article: Peroxisome proliferator-activated receptor and AMP-activated protein kinase agonists protect against lethal influenza virus challenge in mice

(2010) Carson E. Moseley et al.   Influenza and Other Respiratory Viruses

Hypercytokinemia with 2009 pandemic H1N1 (pH1N1) influenza successfully treated with polymyxin B-immobilized fiber column hemoperfusion

(2010) Shinhiro Takeda et al.   INTENSIVE CARE MEDICINE

Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection

(2010) I. Martin-Loeches et al.   INTENSIVE CARE MEDICINE

Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A—An associated respiratory failure and hemodynamic shock

(2010) Pritesh Patel et al.   Pediatric Critical Care Medicine

CROSS-REACTIVE NEUTRALIZING ANTIBODY AGAINST PANDEMIC 2009 H1N1 INFLUENZA A VIRUS IN INTRAVENOUS IMMUNOGLOBULIN PREPARATIONS

(2010) David K. Hong et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Pharmacologic Inhibition of COX-1 and COX-2 in Influenza A Viral Infection in Mice

(2010) Michelle A. Carey et al.   PLoS One

Treating Viral Exacerbations of Chronic Obstructive Pulmonary Disease: Insights from a Mouse Model of Cigarette Smoke and H1N1 Influenza Infection

(2010) Carla M. T. Bauer et al.   PLoS One

Outcomes of adults hospitalised with severe influenza

(2010) N. Lee et al.   THORAX

N-acetyl-l-cysteine (NAC) inhibits virus replication and expression of pro-inflammatory molecules in A549 cells infected with highly pathogenic H5N1 influenza A virus

(2009) Janina Geiler et al.   BIOCHEMICAL PHARMACOLOGY

Confronting the next influenza pandemic with anti-inflammatory and immunomodulatory agents: why they are needed and how they might work

(2009) David S. Fedson   Influenza and Other Respiratory Viruses

Viral Loads and Duration of Viral Shedding in Adult Patients Hospitalized with Influenza

(2009) Nelson Lee et al.   JOURNAL OF INFECTIOUS DISEASES

Clarithromycin Inhibits Type A Seasonal Influenza Virus Infection in Human Airway Epithelial Cells

(2009) M. Yamaya et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Influenza Morbidity and Mortality in Elderly Patients Receiving Statins: A Cohort Study

(2009) Jeffrey C. Kwong et al.   PLoS One

TNF/iNOS-producing dendritic cells are the necessary evil of lethal influenza virus infection

(2009) J. R. Aldridge et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Pioglitazone reduces monocyte activation in type 2 diabetes

(2008) Dario Pitocco et al.   ACTA DIABETOLOGICA

Delayed antiviral plus immunomodulator treatment still reduces mortality in mice infected by high inoculum of influenza A/H5N1 virus

(2008) B.-J. Zheng et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA